- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03893838
Chromatic and Monochromatic Optical Aberrations After Corneal Refractive Surgery
March 27, 2022 updated by: Wrocław University of Science and Technology
Chromatic and Monochromatic Optical Aberrations After Corneal Refractive Surgery - Preliminary Study Assessing Their Prevalence, Methods of Reductions of Symptoms and Time-dependent Changes in Patients Symptoms
Refractive surgeries can be divided into two distinct categories: 1) corneal surgeries (superficial and deep procedures) carried on the surface of the eye and 2) lens surgeries (phakic IOL, refractive lens exchange) - an intraocular intervention, performed in the anterior or posterior chamber or on the lens.
In the proposed protocol focus is on the corneal refractive surgeries impact on monochromatic higher-order aberrations on the one hand and chromatic aberrations on the other.
During the surgery in order to get the patient emmetropic, refractive surgery corrects optical defects by decreasing aberrations of lower orders ) simultaneously increases high-order aberrations (that is perceived by the patient as halo, glare or starburst).
Informations about prevalence and causes of higher order aberrations after refractive surgery are numerous but there is no information about chromatic aberrations.
Study Overview
Status
Active, not recruiting
Conditions
Study Type
Observational
Enrollment (Anticipated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Wrocław, Poland, 50-370
- Department of Optics and Photonics
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients after refractive surgery
Description
Inclusion Criteria:
- patient after corneal refractive surgery at least for 4 months
- post surgical refraction within +/- 0.75 diopter of spherical and +/- 1.0 diopter of cylindrical error
- willing and able to understand and sign an informed consent form.
Exclusion Criteria:
- patient unable to participate in the study
- any corneal diseases, eyes trauma or systemic diseases history; keratoconus or tendency of keratoconus
- corneal macula and obvious pannus; current enrolment in another clinical trial/research project
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Post refractive surgery without HOA
Patients post refractive surgery that do not complain on the high order aberrations such as glare, halo and starburst.
|
|
Post refractive surgery with HOA
Patients post refractive surgery that do complain on the high order aberrations such as glare, halo and starburst.
|
|
Post refractive surgery with rainbow HOA
Patients post refractive surgery that do complain on:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
number of high order and chromatic aberrations after refractive surgery
Time Frame: 6 months
|
number of high order and chromatic aberrations after refractive surgery
|
6 months
|
|
Chromoretinoscopy for near (MEM) and distance
Time Frame: 6 months
|
Conducted with a modified by researchers retinoscopy with distinct filters
|
6 months
|
|
Aberrometry reading for corneal HOA
Time Frame: 6 months
|
Conducted with aberrometer and corneal tomography
|
6 months
|
|
Transverse chromatic aberration
Time Frame: 6 months
|
Conducted with a modified by researchers aniseikonia test (with red and green lenses)
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Hue 100 test
Time Frame: 6 months
|
without and after the introduction of glasses with accommodation support, a blue light filter or concave lenses up to -0,5 diopter
|
6 months
|
|
Change of contrast sensitivity for near vision
Time Frame: 6 months
|
without and after the introduction of glasses with accommodation support, a blue light filter or concave lenses up to -0,5 diopter
|
6 months
|
|
Visual Function Questionaire 25
Time Frame: 6 months
|
Conducted with VFQ-25 test
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Joanna Przeździecka-Dołyk, PhD, Wrocław University of Science and Technology
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2019
Primary Completion (Actual)
February 1, 2022
Study Completion (Anticipated)
February 1, 2024
Study Registration Dates
First Submitted
March 25, 2019
First Submitted That Met QC Criteria
March 26, 2019
First Posted (Actual)
March 28, 2019
Study Record Updates
Last Update Posted (Actual)
March 29, 2022
Last Update Submitted That Met QC Criteria
March 27, 2022
Last Verified
March 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ST001.2018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
We intend to share anonymised data
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.